© 2022 by Mares Ltd.
The future of healthcare is here at Mares Ltd – Your one-stop destination for everything regarding Cell
and Gene Therapeutics!
Considering the impact of microbiology, technology and research, we at Mares welcome you to collaborate,
expand our research and most importantly, focus on the potential of cell therapy.
Founded by Dr. Christian van den Bos in 2007, Mares Ltd upholds the power of gene therapeutics at the highest level. As the 1st director with the sole intention to serve the Biotech and Pharmaceutical industry, Dr. Christian van den Bos aims to redefine scientific stem cell and gene research & development. At Mares, you get to experience the knowledge and expertise of Dr. Christian van den Bos, who is a Qualified Person (QP) based on European standards.
He has played an active part in developing and upgrading ATMPs for more than 20 years including 10 years in US-based R&D activities. Furthermore, he has served in high-level managerial positions at Lonza (Germany), Cytograft (USA), Symetis (Switzerland & Germany), ViaCell (USA), Kourion (Germany) and Martek Biosciences (USA).
At Mares Ltd, Vijay Raghavan is responsible for Business Development & Strategic Partnering.
Vijay has over 25 years of experience across industries like Healthcare, Biotech and IT to name a few. Some of his prestigious global clients across India, USA, APAC and Sri Lanka include powerhouses such as TATA, Aditya Birla, Manipal Education & Medical Group.
With a bachelor degree in Economics from LU and a masters from CGU, Vijay Raghavan is a specialist in New Market Entry, International Relations and Cross-Culture Domains.